IntracranIal sarcoId granuloma as an extensIon of severe sInonasal sarcoIdosIs Intracranial sarcoid granuloma as an extension of severe sinonasal sarcoidosis
Introduction
Sarcoidosis is a chronic, multisystem, granulomatous disease of unknown etiology that manifests with a wide range of symptoms and clinical findings. Predominantly a disease of the pulmonary system, it can affect nearly every part of the body. Head and neck involvement is rather uncommon, occurring in 9 to 15% of patients. 1 Central nervous system involvement has also been reported, although the incidence of diagnosed neurosarcoidosis is only 5%. 2 Sinonasal sarcoidosis, either isolated or in association with other sites, demonstrates a particularly recalcitrant course that is characterized by chronic inflammatory rhinosinusitis, nasal crusting, epistaxis, septal erosion or synechiae, obstruction, recurrent infections, and/or anosmia. 3, 4 The diagnosis is usually based on clinical findings followed by pathologic confirmation via biopsy of the suspected area. Steroids are the mainstay of treatment; they frequently provide symptomatic relief, and they sometimes halt the progression of what is a lifelong disease. 1, 4 Unfortunately, patients with severe cases may not respond to medical management and may develop devastating morbidity. We present the case of a patient with extensive sinonasal sarcoidosis who subsequently experienced symptomatic intracranial extension that required surgical intervention.
Case report
A 46-year-old woman presented to our outpatient clinic with a 1-year history of anosmia and nasal crusting. She reported being previously diagnosed with sarcoidosis following a nasal biopsy, but she had been noncompliant with her nasal hygiene regimen. On examination, extensive crusting was noted along the nasal septum bilaterally, as well as on the posterior pharyngeal wall.
The patient was placed on a topical nasal steroid, a saline spray, and mupirocin ointment, and she experienced an initial symptomatic improvement. However, despite continued long-term management efforts in this regard, subsequent follow-up visits showed stability, but persistence, of her nasal disease up to the skull base. Oral prednisone was attempted on two occasions, but it was stopped because of intolerable side effects.
Three years after her initial presentation, the patient returned with complaints of new-onset headaches and peripheral vision disturbances. Computed tomography (CT) and magnetic resonance imaging (MRI) detected a 2-cm enhancing lesion in the left frontal lobe with marked edema and evidence of cribriform plate inva-sion adjacent to pansinus disease (figure). Intranasal cultures and biopsy demonstrated acute and chronic inflammation. Findings on imaging of the chest were normal.
Following a neurosurgical evaluation, the patient was taken to the operating room. She underwent bilateral functional endoscopic sinus surgery followed by bifrontal craniotomy with resection of the frontal lobe/skull base mass, cranialization of the frontal sinuses, and reconstruction of the anterior skull base floor. An interesting intraoperative finding was invasion of the olfactory tracts bilaterally; the left side was almost entirely replaced by granular tumor. Permanent histology demonstrated noncaseating granulomas amid chronic inflammation, a finding consistent with a diagnosis of neurosarcoidosis, presumably an intracranial extension of the preexisting sinonasal disease.
Postoperatively, the patient's visual acuity returned to normal, and no evidence of cerebrospinal fluid leak was observed. At 2 years of follow-up, repeat endoscopy and imaging revealed no specific signs of persistent or recurrent disease. However, the patient remained anosmic and had mild crusting.
Discussion
Sinonasal sarcoidosis may pose a considerable challenge in terms of management, and it has the potential for causing significant morbidity. Therefore, it is of paramount importance that clinical suspicion be maintained to facilitate early diagnosis and therapy. The gold standard for diagnosis remains histologic evidence of noncaseating granulomas, which is typically obtained from biopsy of the inferior turbinate or septal mucosa. Additional diagnostic criteria may include refractory chronic rhinosinusitis, an elevated angiotensin-converting enzyme level, a positive gallium scan, and evidence of systemic sarcoidosis. Imaging studies such as sinus CT and chest films, although not routinely required, can help further define the extent of disease.
The mainstay of treatment for sinonasal sarcoidosis is steroid therapy, which can be administered in topical, intralesional, and oral regimens. While positive results have been reported overall with this treatment modality, the degree of clinical improvement remains considerably variable from patient to patient. Moreover, because the cessation of steroid therapy might hasten the return of symptoms, patients require lifelong maintenance therapy. Unfortunately, in view of the numerous untoward side effects of steroids, some patients who stay on them may only be trading one set of symptoms for another.
Since the granulomatous process may induce the permanent destruction of mucus-producing glands and cilia, the role and effectiveness of sinus surgery in the restoration of mucociliary clearance and sinus drainage and in the management of symptoms has been investigated. Unfortunately, the infrequency of sinonasal sarcoidosis has limited most studies to only a few patients, and solid long-term data are not yet available. Short-term findings have included symptomatic relief, quality-of-life improvement, easier office debridement, and a reduction in the need for ongoing steroid therapy. 3, 4 However, relapse is frequently seen during subsequent follow-up.
Despite treatment, complications may arise, as is evidenced by the case presented here. While the incidence of neurosarcoidosis is higher than that of sinonasal sarcoidosis, it is rare for the former to occur as a result of direct extension from the nose. 2 A single case of such invasion was described by Milgrim and Cohen, who found meningeal and frontal lobe involvement on MRI; fortunately, their patient exhibited a dramatic response to prednisone therapy. 5 To the best of our knowledge, ours is the first reported case in which an actual sarcoid granuloma arose intracranially from cribriform plate erosion. Although cranial nerve deficits and perineural spread have been reported, VIth and VIIth nerve palsies are more common; direct infiltration of the olfactory tract with resultant total anosmia is extremely uncommon. 2, 5 Surgery was deemed appropriate for our patient in light of her progressively symptomatic disease and the relative failure/intolerance of her initial medical therapy. During follow-up, we saw a complete remission of her intracranial disease and a significant improvement in her sinonasal symptoms, although her anosmia is likely permanent.
In conclusion, sarcoidosis is variable in its presentation and extent. Since its initial manifestations may be localized to the head and neck, clinical suspicion, early recognition, and aggressive intervention are important. Fortunately, most patients achieve significant improvement in their symptoms with treatment. Although surgery is not recognized as a first-line treatment modality, it might play a role in the care of certain patients. A multidisciplinary approach may be warranted for this frequently multisystem disease.
